Consultant, Jubilant Drug Discovery , Bangalore
Dr. VN Balaji received his Ph.D in Molecular Biophysics in 1981 from Indian Institute of Science, Bangalore, India. He did his Post-doctoral research at Department of Chemistry, Rutgers University, New Jersey, USA (1981-83).
He has over 3 decades of pharmaceutical industrial experience (from molecular design to scientific management). He worked at Lederle Laboratories (Pearl River, NY, USA), Allergan Pharmaceuticals (Irvine, CA, USA), Immuno Pharmaceuticals (San Diego, CA, USA), Monsanto (St. Louis, Missouri, USA and R&D Centre, Bangalore, India) and Jubilant Biosys (Bangalore, India). In 2001, he co-founded Jubilant Biosys, Bangalore, India and mentored to establish state-of-the-art drug discovery laboratory including informatics, high throughput screening, molecular design, structural biology, invitro and invivo biology, DMPK etc.
He has co-authored more than 40 publications and 20 patents. He contributed to the molecular design of the anti-acne drug “Tazaroc” marketed by Allergan Pharmaceuticals. He initiated Endothelin antagonist programme at Immuno Pharmaceuticals and contributed to the molecular design of anti-hypertensive drug “Thelin”. He mentored several successful drug discovery collaboration initiatives.
Dr. Balaji was formally retired from his services on 31st March 2012 as the Chief Scientific Mentor of Jubilant Biosys and re-appointed as member of the Scientific Advisory Board w e f 1st April 2012. He is a member of more than 8 national and international organizations including Confederation of Indian Industry (CII). He is a member of Editorial Advisory Board hemical Biology & Drug Design.